Clinical assessment of local use of cortisone in cases of nasal allergy

ABSTRACT

50 patients with allergic rhinitis were treated with intranasal beclomethasone dipropionate Aerosol [Kenalog] and Intranasal injection with triamciolone diacetate [Kenalog]. The beclomethasone was administered at 50 micro g in each nostril four times daily and the triamcinolone diacetate was injected in the middle third of inferior turbinate using Batman 5 ml. metal and glass syringe. 2 cc. were injected in each turbinate [40 mg]. Treatment was allocated on a randomized bases. Both groups received treatment for two weeks and in the second group the injection was repeated after one week. Follow up was continued for 1 months for both groups. Some case were followed up from 6 months to 1 year, utilizing patient daily symptoms, diary cards, clinical assessment an local examination of the nasal mycosa before and after treatment, nasal smeers for eosinophils and other cell's blood analysis for eosinophils. It was concluded that both intranasal beclomethasone dipropoinate aerosol and intranasal injection of triamcinolone diacetate caused reduction of the symptom associated with allergic rhinitis. No side effects were noted nor were there any adverse changes observed in the state of the nasal mucosa